1. Vitamin D3-fortified milk did not affect glycemic control, lipid profile, and anthropometric measures in patients with type 2 diabetes, a triple-blind randomized clinical trial
- Author
-
Fatemeh Sadeghi, Masoumeh Akhlaghi, Mahdi Roshanzamir, Mohammad Amin Hanifpour, and Saedeh Salehi
- Subjects
Vitamin ,medicine.medical_specialty ,Nutrition and Dietetics ,medicine.diagnostic_test ,business.industry ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Type 2 diabetes ,medicine.disease ,Gastroenterology ,vitamin D deficiency ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Internal medicine ,Diabetes mellitus ,medicine ,Vitamin D and neurology ,030212 general & internal medicine ,Lipid profile ,business ,Body mass index ,Glycemic - Abstract
The effect of vitamin D on glycemic status of diabetes patients is controversial. The objective was to assess the effect of vitamin D3-fortified milk on cardiometabolic markers of patients with type 2 diabetes. In this randomized triple-blind, placebo-controlled trial, 102 patients (34 males and 68 females) aged 31–74 years with type 2 diabetes were randomized to receive either 250 ml unfortified or 250 ml 1000 IU vitamin D3-fortified milk daily for 9 weeks. Anthropometric characteristics, blood pressure, and serum levels of glucose, insulin, and lipids were determined at baseline and after 9 weeks. Serum 25-hydroxy vitamin D concentrations improved in the fortified milk group compared to the control group (+14 ± 20 vs. +4 ± 17 ng/ml; P = 0.001). Both groups showed significant increases in serum calcium (P
- Published
- 2018